Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis?

× No keyword cloud information.

15 in total

1. High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.

Authors: Mikel Alberdi-Saugstrup; Marek Zak; Susan Nielsen; Troels Herlin; Ellen Nordal; Lillemor Berntson; Anders Fasth; Marite Rygg
Journal: Rheumatol Int Date: 2017-03-10 Impact factor: 2.631

Review 2. From bench to bedside and back again: translational research in autoinflammation.

Authors: Dirk Holzinger; Christoph Kessel; Alessia Omenetti; Marco Gattorno
Journal: Nat Rev Rheumatol Date: 2015-06-16 Impact factor: 20.543

Review 3. Tocilizumab: a review of its use in the treatment of juvenile idiopathic arthritis.

Authors: James E Frampton
Journal: Paediatr Drugs Date: 2013-12 Impact factor: 3.022

4. [Recommendations of the German rheumatology society on the use of tocilizumab in rheumatoid arthritis].

Authors: A Gause; A Rubbert-Roth; H Michels; M Gaubitz; W-J Mayet
Journal: Z Rheumatol Date: 2010-06 Impact factor: 1.372

5. Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis.

Authors: Shumpei Yokota; Toshio Tanaka; Tadamitsu Kishimoto
Journal: Ther Adv Musculoskelet Dis Date: 2012-12 Impact factor: 5.346

6. Low pretreatment levels of myeloid-related protein-8/14 and C-reactive protein predict poor adherence to treatment with tumor necrosis factor inhibitors in juvenile idiopathic arthritis.

Authors: Mikel Alberdi-Saugstrup; Susan Nielsen; Pernille Mathiessen; Claus Henrik Nielsen; Klaus Müller
Journal: Clin Rheumatol Date: 2016-08-25 Impact factor: 2.980

Review 10. The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases.

Authors: Silvia Federici; Alberto Martini; Marco Gattorno
Journal: Front Immunol Date: 2013-10-31 Impact factor: 7.561

Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis?